sb 203580 has been researched along with fk 409 in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (fk 409) | Trials (fk 409) | Recent Studies (post-2010) (fk 409) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 146 | 0 | 11 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, H; Yamamoto, T; Yuyama, K | 1 |
1 other study(ies) available for sb 203580 and fk 409
| Article | Year |
|---|---|
Low concentrations of nitric oxide (NO) induced cell death in PC12 cells through activation of p38 mitogen-activated protein kinase (p38 MAPK) but not via extracellular signal-regulated kinases (ERK1/2) or c-Jun N-terminal protein kinase (JNK).
Topics: Analysis of Variance; Animals; Blotting, Western; Cell Death; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Imidazoles; JNK Mitogen-Activated Protein Kinases; Nitric Oxide; Nitric Oxide Donors; Nitro Compounds; p38 Mitogen-Activated Protein Kinases; PC12 Cells; Pyridines; Rats; Time Factors | 2006 |